Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans Mickley

Showing results (61-70 of 137) with videos related to

Pageof 14
Sort By:
Interactive Cardiovascular and Thoracic Surgery|January 29, 2014
Optimal cut-off value for cardiac troponin I in ruling out Type 5 myocardial infarctionPeter Hartmund Jørgensen, Mads Nybo, Marianne Kjær Jensen, et al.
BMJ Open|December 25, 2017
Clinical features and prognosis of patients with acute non-specific chest pain in emergency and cardiology departments after the introduction of high-sensitivity troponins: a prospective cohort studyNivethitha Ilangkovan, Hans Mickley, Axel Diederichsen, et al.
The American Journal of Medicine|July 17, 2013
Classification of myocardial infarction: frequency and features of type 2 myocardial infarctionLotte Saaby, Tina Svenstrup Poulsen, Susanne Hosbond, et al.
The American Journal of Medicine|January 15, 2016
Prognostic Impact of Myocardial Injury Related to Various Cardiac and Noncardiac ConditionsLaura Sarkisian, Lotte Saaby, Tina S Poulsen, et al.
Journal of Proteomics|December 27, 2013
Plasma proteome profiling of atherosclerotic disease manifestations reveals elevated levels of the cytoskeletal protein vinculinLars P Kristensen, Martin R Larsen, Hans Mickley, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|July 28, 2017
Lack of association between cystatin C and different coronary atherosclerotic manifestationsTrine R Larsen, Oke Gerke, Axel C P Diederichsen, et al.
The American Journal of Medicine|December 25, 2017
Different Causes of Death in Patients with Myocardial Infarction Type 1, Type 2, and Myocardial InjurySascha Lambrecht, Laura Sarkisian, Lotte Saaby, et al.
The American Journal of Medicine|November 24, 2015
Clinical Characteristics and Outcomes of Patients with Myocardial Infarction, Myocardial Injury, and Nonelevated TroponinsLaura Sarkisian, Lotte Saaby, Tina S Poulsen, et al.
Danish Medical Journal|September 7, 2012
Significant improvement in statin adherence and cholesterol levels after acute myocardial infarctionHilde Vaiva Tonstad Brogaard, Morten Ganderup Køhn, Oline Sofie Berget, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|January 25, 2014
Lipocalin-type prostaglandin D synthase is not a biomarker of atherosclerotic manifestationsSusanne E Hosbond, Axel C P Diederichsen, Lise Pedersen, et al.
Pageof 14

Showing results (61-70 of 137) with videos related to

Sort By:
Pageof 14
Interactive Cardiovascular and Thoracic Surgery|January 29, 2014
Optimal cut-off value for cardiac troponin I in ruling out Type 5 myocardial infarctionPeter Hartmund Jørgensen, Mads Nybo, Marianne Kjær Jensen, et al.
BMJ Open|December 25, 2017
Clinical features and prognosis of patients with acute non-specific chest pain in emergency and cardiology departments after the introduction of high-sensitivity troponins: a prospective cohort studyNivethitha Ilangkovan, Hans Mickley, Axel Diederichsen, et al.
The American Journal of Medicine|July 17, 2013
Classification of myocardial infarction: frequency and features of type 2 myocardial infarctionLotte Saaby, Tina Svenstrup Poulsen, Susanne Hosbond, et al.
The American Journal of Medicine|January 15, 2016
Prognostic Impact of Myocardial Injury Related to Various Cardiac and Noncardiac ConditionsLaura Sarkisian, Lotte Saaby, Tina S Poulsen, et al.
Journal of Proteomics|December 27, 2013
Plasma proteome profiling of atherosclerotic disease manifestations reveals elevated levels of the cytoskeletal protein vinculinLars P Kristensen, Martin R Larsen, Hans Mickley, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|July 28, 2017
Lack of association between cystatin C and different coronary atherosclerotic manifestationsTrine R Larsen, Oke Gerke, Axel C P Diederichsen, et al.
The American Journal of Medicine|December 25, 2017
Different Causes of Death in Patients with Myocardial Infarction Type 1, Type 2, and Myocardial InjurySascha Lambrecht, Laura Sarkisian, Lotte Saaby, et al.
The American Journal of Medicine|November 24, 2015
Clinical Characteristics and Outcomes of Patients with Myocardial Infarction, Myocardial Injury, and Nonelevated TroponinsLaura Sarkisian, Lotte Saaby, Tina S Poulsen, et al.
Danish Medical Journal|September 7, 2012
Significant improvement in statin adherence and cholesterol levels after acute myocardial infarctionHilde Vaiva Tonstad Brogaard, Morten Ganderup Køhn, Oline Sofie Berget, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|January 25, 2014
Lipocalin-type prostaglandin D synthase is not a biomarker of atherosclerotic manifestationsSusanne E Hosbond, Axel C P Diederichsen, Lise Pedersen, et al.
Pageof 14